CAR T-cell therapy harnesses the power of the immune system, particularly T cells, to combat cancer effectively. The process begins by extracting a patient's T cells from their blood. These cells are then genetically engineered in a laboratory to express CARs on their surface. CARs are synthetic receptors that enable T cells to recognize specific antigens present on cancer cells. Download report @ https://www.delveinsight.com/report-store/chimeric-antigen-receptor-car-t-cell-therapy-market?utm_source=report&utm_medium=promotion&utm_campaign=kpr